Physician profile
Scott A Spiro
NPI 1093896250
$14,148.04
in general payments reported to CMS, 2019-2025
13 companies · $473 in 2025
The $473 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,927 · 2020: $401 · 2021: $1,433 · 2022: $2,511 · 2023: $2,009 · 2024: $2,394 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,016 · Food and Beverage: $861.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,015.50 |
| Food and Beverage | $860.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $9,302.42 | 2019-2023 | |
| Abbvie INC. | $3,780.29 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Mentor Worldwide LLC | $364.86 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Musculoskeletal Transplant Foundation INC. | $271.07 | 2019-2025 | |
| Tela Bio, INC. | $121.86 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Merz North America, INC. | $119.54 | 2023 | Xeomin |
| Integra Lifesciences Corporation | $59.41 | 2024-2025 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Tepha INC | $26.32 | 2019 | |
| Ethicon US, LLC | $25.99 | 2024 | Vistaseal |
| Axogen | $23.44 | 2025 | |
| Davol INC. | $22.34 | 2025 | Galaflex Lite |
| Arteriocyte Medical Systems, INC. | $15.96 | 2019 | |
| Endo Pharmaceuticals INC. | $14.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Spiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.